1. ChemStewards Educating Members about Benefits of New Optimization Portal

    Last October SOCMA launched a new ChemStewards® Portal as part of the 2014 ChemStewards Optimization Project. This portal is an efficient environmental, health, safety and security (EHS&S) management system that allows our members to save time and effort by having all ChemStewards and related EHS&S documents in a centralized, web-based repository. 
  2. 2015 Global Chemical Regulations Conference & Expo

    Remarks by Lawrence D. Sloan, President & CEO, SOCMA, 2015 GlobalChem Conference & Expo, Hilton Baltimore, Baltimore, MD - Good morning everyone and welcome to Day Two of this year’s Global Chemical Regulations Conference.  As Bill mentioned, my name is Larry Sloan and I am President and CEO of the Society of Chemical Manufacturers & Affiliates.  It is a pleasure to be with you this morning and open today’s proceedings.
  3. SOCMA Committed to Strengthening Nation’s Workforce

    The Society of Chemical Manufacturers and Affiliates (SOCMA) is committed to playing a role in strengthening our nation’s workforce. Our Chemical Process Operator Training (CPOT) program is designed to provide the next generation of chemical/process operators with basic skills they need to secure good paying jobs and opportunities for job advancement as they navigate their careers. But it all starts with a solid foundation of learning.
  4. Where it all begins – the TSCA Pre-Manufacturing Notice (PMN)

    Complying with the Toxic Substances Control Act, our nation’s chemical control law, can be complicated and costly. Under TSCA section 16(a), the Environmental Protection Agency (EPA) can impose penalties of up to $37,500 each day, so the consequences of non-compliance can be quite serious.
  5. BPTF Voices Concern to FDA about Reduction of Domestic Facility Inspection Frequency

    SOCMA’s Bulk Pharmaceuticals Task Force has long been an advocate and supporter of the Food and Drug Administration’s (FDA) Generic Drug User Fee (GDUFA) program and its goal to consistently perform risk-based inspections of both U.S. and foreign drug manufacturing facilities. But concerns were recently raised when a memo from the Department of Health and Human Services disclosed a 40 percent decrease in the number of inspections of U.S. drug facilities in 2014 and 2015 – a move that could significantly impact the generic active pharmaceutical ingredient (API) manufacturers the Task Force represents.

  6. Bulk Pharmaceuticals Task Force Alarmed at Reduction in Compliance Inspections

    Washington, D.C. – The Bulk Pharmaceuticals Task Force (BPTF), which is an affiliate of the Society of Chemical Manufacturers and Affiliates (SOCMA), issued a letter on Tuesday to the Food and Drug Administration (FDA) asking that the agency ensure the frequency of inspections for any domestic Active Pharmaceutical Ingredient (API) manufacturer remains consistent.
  7. SOCMA's Bulk Pharmaceuticals Task Force Welcomes Waiver for U.S. API Imports to Europe

    Washington, DC – The Bulk Pharmaceuticals Task Force (BPTF) today hailed an announcement from European officials granting U.S. drug makers an exemption from new export requirements, thereby ensuring a continued supply of safe drugs into the EU from the U.S.
  8. Could Sequestration Derail Generic Drug User Fee Program?

    With sequestration looming, SOCMA’s Bulk Pharmaceuticals Task Force is concerned the program it worked years to bring about – Generic Drug User Fees (GDUFA) – could be derailed by budget cuts set to take effect March 1. GDUFA was signed into law by President Obama in July and took effect in October.
  9. SOCMA’s Bulk Pharmaceuticals Task Force Hails Signing of FDA Reform Act into Law

    Washington, DC – In a major victory for the American people, President Obama today signed the Food and Drug Administration's user fee bill into law, making it possible for the federal government to speed approval of lifesaving medicines, reduce drug shortages and improve the quality and availability of drugs in the U.S.
  10. SOCMA’s Bulk Pharmaceuticals Task Force Asks Congress to Increase Inspections of Foreign Drug Manufacturing Facilities

    Washington, DC – The Bulk Pharmaceuticals Task Force (BPTF), an affiliate organization of the Synthetic Organic Chemical Manufacturers Association (SOCMA) testified today on the Food & Drug Administration’s inadequate inspection regime for foreign manufacturers of drug ingredients.  The testimony was before the House Energy & Commerce Committee’s Subcommittee on Oversight and Investigation.
Page 36 of 36First   Previous   27  28  29  30  31  32  33  34  35  [36]  Next   Last   
Return Home